Diagnostic Reading #15: Five “Must Read” Articles on HIT and Radiology
Reading Time: 3 minutes read
Options for managing medical imaging data; and patients’ views on AI are in the news.
This week’s articles in Diagnostic Reading include: biomarker may predict better breast cancer treatment therapy; which option is the best for managing imaging data?; skin scent may lead to Parkinson skin swab test; imaging patients are confident but concerned about AI; and CT colonography awareness and utilization still low in U.S.
PET scans show biomarkers could spare some breast cancer patients from chemotherapy – Imaging Technology News
A new study of positron emission tomography (PET) scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy. The study was conducted by researchers at the Johns Hopkins Kimmel Cancer Center in an effort to further individualize therapy and avoid over-treating patients. The de-escalation of treatment strategies aims to minimize toxicity while maintaining efficacy.
In most health systems and imaging facilities today, PACS is only a small part of medical imaging workflow and storage. Many organizations, if they haven’t yet, are ready or in need of replacing or upgrading their PACS. Radiology Today reviews the options for managing imaging data.
‘Super smeller’ could lead to Parkinson skin swab test – Healthcare in Europe
A study has identified chemicals in the skin responsible for a unique scent in people with Parkinson’s disease. The chemicals can be detected in an oily substance secreted from the skin called sebum, the researchers found. These findings suggest Parkinson’s disease could one day be diagnosed from skin swabs, potentially leading to new tests. Currently there are no tests for Parkinson’s disease.
Imaging patients are concerned—but optimistic—about AI – Health Imaging
Radiology patients are confident artificial intelligence (AI) will improve healthcare workflow and efficiency. However, they are skeptical of the tech itself and remain unsure of how AI will factor into the patient experience, according to a recent study published in the Journal of the American College of Radiology. The authors said that, while physicians have been focused on the clinical benefits of AI—increased diagnostic certainty, quicker turnaround and reduced burnout, to name a few—patients remain “important but still neglected stakeholders” as the technology evolves.
CT colonography utilization remains low in US – Radiology Business
CT colonography awareness and utilization in the United States are both trending in the wrong direction, according to a study published by the Journal of the American College of Radiology. Overall, CT colonography utilization dropped from 1.2 percent in 2010 to 0.9 percent five years later.
#diagnosticreading #PACS #AI